On October 7, 2020, the Nobel Assembly awarded the 2020 Nobel Prize in Chemistry to Jennifer Doudna and Emmanuelle Carpentier for developing the tools to edit DNA. They showed that CRISPR/Cas9 genetic scissors can be reprogrammed to make specific and precise changes to the DNA contained in living cells. Their discovery has revolutionized life sciences and has many potential applications in medicine and other areas. Dr. Jennifer Anne Doudna is a Biochemist and Professor at the University of California, Berkeley, which is IRIS CEO Simon Chin’s alma mater.
Nobel Laureate Jennifer Doudna and IRIS CEO Simon Chin
Dean Phillip R. Oppenheimer and IRIS CEO Simon Chin
Phillip Oppenheimer is Dean of University of the Pacific’s Thomas J. Long School of Pharmacy and Health Sciences. Dean Oppenheimer was named California Pharmacists Association Pharmacist of the Year in 2004, American College of Apothecaries Dean of the Year in 2005, and American Pharmacists Association-Academy of Student Pharmacists Most Outstanding Dean of the Year in 2014. In 2017, he was inducted into the California Pharmacists Association Hall of Fame. IRIS CEO Simon Chin has been serving with Dean Oppenheimer on the Industrial Advisory Board of the Thomas J. Long School of Pharmacy and Health Sciences for 8 years.
Nobel Laureate James P. Allison and IRIS CEO Simon Chin
On October 1, 2018, the Nobel Assembly awarded the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. Their seminal discoveries constitute a landmark in the fight against cancer. Dr. Alison served as professor of molecular and cell biology at UC Berkeley and director of the Cancer Research Laboratory from 1985 – 2004. He is Chair of the Department of Immunology and Executive Director of the Immunotherapy Platform at MD Anderson, currently ranked as the #1 Cancer Center in the US.
Health and Wellness Experts
From left to right: Beverly Maloney-Fishback, CEO, Founder & Publisher of Organic Spa Media, LTD; Michael Roizen, MD, Chief Wellness Officer at the Cleveland Clinic; Dr. Elissa Epel, UCSF Professor of Psychiatry, Director of the Aging, Metabolism, and Emotions Center, and Director of the Consortium for Obesity Assessment, Study, & Treatment; Dr. Jay Williams, acclaimed physiologist and medical nutritionist, author, researcher, and health and wellness consultant; Dean Ornish, MD, UCSF Professor of Medicine, and author of Dr. Dean Ornish’s Program for Reversing Heart Disease, Eat More, Weigh Less and The Spectrum; Simon Chin, President & CEO of IRIS Wellness Labs.
Frost and Sullivan North American Technology Innovation Award in Pharmacology
Frost and Sullivan, in recognizing IRIS Wellness Labs’ parent company, IRIS Biotechnologies, with their Award in Pharmacology, stated “For patients, this technology would be pivotal in yielding a personalized treatment regimen, with the greatest possibility of success, for each individual patient’s particular type of disease such as cancer, heart disease, diabetes, or gene-related metabolic disorders.” IRIS Wellness Labs was launched based upon this and other technologies.
World's Largest Gathering for Laboratory Medicine at AACC
At the American Association for Clinical Chemistry conference (AACC), IRIS CEO Simon Chin was a panelist discussing the integration of data for computational and clinical outcomes.
According to AACC, this is “a panel drawn from the healthcare professionals and diagnostic industry leaders who have a vision for how this innovation evolution might look and insight into what laboratorians and IVD manufacturers may expect. Since the laboratory produces an overwhelming amount of data that challenges today’s legacy architecture, the future which will include extensive data arrays drawn from next generation sequencing and companion diagnostics, call for contemporary tools and systems to deliver the promise of tomorrow’s world.”
The panel was moderated by Bob McGonnagle, the Publisher of the College of American Pathologists trade journal, CAPToday. Mr. McGonnagle invited Mr. Chin to speak at AACC after Mr. McGonnagle heard Mr. Chin’s invited presentation at BIO, the world’s largest biotech conference.
Mr. Chin was also an invited speaker at the Medicine in the 21st Century Conference.
PharmaVOICE recognized Mr. Chin as one of the top 100 most inspiring people in the life sciences industry.
Mr. Chin has four patents, including, US patent 8,693,751, “Artificial Intelligence System for Genetic Analysis.” He has been on the University of Pacific’s Thomas J. Long School of Pharmacy and Health Sciences Industrial Advisory Board for seven years. The board includes key people from Novartis, Gilead, Supergen, Exact Sciences, UC Berkeley, and other entities.
Charles Wiseman, MD, and IRIS CEO Simon Chin
IRIS Wellness Labs is proud to have Dr. Wiseman on our staff. Dr. Wiseman previously served as Director of the Breast Cancer Basic Research Laboratory at the University of Texas M.D. Anderson Hospital. He is a pioneer the field of cancer vaccine therapeutics. Dr. Wiseman is Clinical Professor of Medicine in the Division of Medical Oncology, Keck-USC School of Medicine, and previously was Acting Chief of the Division of Oncology/Hematology at White Memorial Medical Center. Dr. Wiseman has been cited in US News Top Doctors yearly since 2002. Dr. Wiseman received his MD degree from UCLA.
IRIS Scientific Advisory Board
We are delighted that an eminently qualified scientific advisory board guides our parent company, which then support us with medical and scientific advice, patents, and leading-edge technoloogy development. IRIS Biotechnologies’ scientific advisory board includes Professor Walter Hittelman at M.D. Anderson Cancer Center, Professor Wei Zhang at Wake Forest School of Medicine, Professor Weidong Le, MD, PhD, at Baylor College of Medicine, Professor Norman Tien, University of Hong Kong’s Dean of the Faculty of Engineering, and Charles Wiseman, MD, a Beverly Hills oncologist and immunologist, who is also on IRIS Wellness Labs medical team.
American Society of Clinical Oncology (ASCO) Conference: Simon Chin and Laura Esserman, MD
Dr. Laura Esserman, a practicing surgeon, professor of Surgery and Radiology, a faculty member, practicing surgeon, breast cancer oncology specialist and the director athas been at the forefront of efforts to change the delivery of breast cancer services as well as information systems used to support both research and patient care.
Nobel Laureate and Former President of the Howard Hughes Medical Institute, Dr. Thomas Cech and IRIS CEO Simon Chin at HHMI
Dr. Thomas Robert Cech received the 1989 Nobel Prize in Chemistry with Sidney Altman, for their discovery of the catalytic properties of RNA. As president of Howard Hughes Medical Institute, he promoted science education. Dr. Cech completed his PhD in Chemistry at the University of California, Berkeley.
Simon Chin, Susie Ellis with Dr. Richard Carmona
IRIS CEO Simon Chin, GWS CEO Susie Ellis, and Former US Surgeon General Dr. Richard Carmona at the Global Wellness Summit.
Recognized as a leading authorities on the multi-sector wellness industry, Ms. Ellis is currently Chairman and CEO of the Global Wellness Institute (GWI), heading up the organization’s annual Global Wellness Summit and Global Wellness Tourism Congress.
Dr. Carmona, the seventeenth Surgeon General of the United States, is now the Vice Chairman of the Canyon Ranch resort, President of the non-profit Canyon Ranch Institute, and a professor at the Mel and Enid Zuckerman College of Public Health at the University of Arizona.
Simon Chin, Dr. Oz and Susie Ellis
IRIS CEO Simon Chin with Dr. Oz and Susie Ellis at the 2017 Global Wellness Summit. Chin was a panelist on DNA Testing, along with Dr. Paul Limburg, Medical Director, Mayo Clinic, and others.
Dr. Oz (Mehmet Cengiz Öz), a cardiothoracic surgeon and professor at Columbia University is also a well known best-selling author and television personality. His philosophy is to take away the barriers between the patient and their medicine. The Dr. Oz Show, a daily television program, focuses on medical issues and personal health.
Susie Ellis, Dr. Andrew Weil and Simon Chin
Andrew Weil, MD is a Lovell-Jones Professor of Integrative Rheumatology, Clinical Professor of Medicine, and Professor of Public Health at the University of Arizona. He is a leader and pioneer in the field of integrative medicine, a healing oriented approach to health care, encompassing body, mind, and spirit.
IRIS CEO Simon Chin Running the Napa Valley Marathon
IRIS CEO Simon Chin ran 26.2 miles to raise funds for the Leukemia and Lymphoma Society. Mr. Chin believes in giving back to society. He served on the advisory board of Santa Clara University’s Ignatian Center for Jesuit Education for 11 years, on the board of directors of the YMCA of Silicon Valley, which serves a million people through its 12 branches in Santa Clara County for 6 years, and as a member of the Saratoga Rotary Club, which is part of Rotary International, for 18 years helping people all over the world. Rotary International has 1.2 million members making positive, lasting change in communities at home and abroad.